|
Generation of an ATM knock in mouse with the breast-cancer susceptibility mutation, 7271T>G
Dr Jeremy Arnold, Queensland Institute of Medical Research, Australia
|
|
Increased cancer risk of heterozygotes with NBS1 founder mutation
Prof Karl Sperling, Institute of Human Genetics, Charité - Universitätsmedizin Berlin, Germany
|
|
Nijmegen Breakage Syndrome: hypomorphic mutation, protein expression and phenotypic variability
Martin Digweed, Institut für Humangenetik, Charité - Universitätsmedizin Berlin., Germany
|
|
LKB1 tumor suppressor gene alterations in sporadic lung adenocarcinomas
Montserrat Sanchez-Cespedes, Spanish National Cancer Centre, Spain
|
|
Prostate Specific Antigen(PSA) gene polymorphism and its Interaction with Androgen Receptor Trinucleotide Repeats (CAG) in Prostate Cancer
Dr Rama Devi Mittal, Sanjay Gandhi Post Graduate Institute of Medical Sciences, India
|
|
Evidence for a broader role of the tumor suppressor BRCA1 at specific genomic sites during their replication
Gayle J Pageau, University of Massachusetts Medical School, United States
|
|
Telomere-mediated genomic instability in breast tumour cells and in cells from mice lacking breast cancer genes
Dr Prakash Hande, Department of Physiology, Yong Loo Lin School of Medicine, National University of Singapore
|
|
Genetic mapping in Trp53+/- mice identifies DMBT1 as a potential modifier of breast cancer risk
Dr Anneke C Blackburn, Australian National University, Canberra ACT, Australia
|